NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I, Phase II, Direct to Phase II, and Fast-Track applications. The STTR program supports feasibility studies to later stage research and development needed to develop a commercial product. The program aims to help SBCs that partner with a nonprofit research institution bring scientific innovations to the marketplace. Key areas of research include cardiovascular diseases, cancer, diabetes, and neurological disorders, among others. • The program will utilize the R41/R42 activity code. • United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components are encouraged to apply. • Collaborative investigations combining expertise will be encouraged. • The award will provide funding for up to 2 years, with the possibility of renewal. • The program aims to support the development of innovative technologies that can be commercialized and bring benefits to the public.